Global X Genomics & Biotechnology ETF (GNOM)
NASDAQ: GNOM · Real-Time Price · USD
8.64
-0.09 (-0.97%)
At close: Jul 18, 2025, 4:00 PM
8.60
-0.04 (-0.41%)
After-hours: Jul 18, 2025, 7:43 PM EDT
GNOM Holdings Information
GNOM is an equity ETF with a total of 50 individual holdings. The top holdings are CRISPR Therapeutics AG stock at 5.44%, Alnylam Pharmaceuticals at 5.07%, Illumina at 4.83%, Moderna at 4.59%, and Legend Biotech at 4.41%.
Total Holdings
50
Top 10 Percentage
44.53%
Asset Class
Equity
ETF Category
Health
Assets
43.04M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | 5.44% |
| 2 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.07% |
| 3 | ILMN | Illumina, Inc. | 4.83% |
| 4 | MRNA | Moderna, Inc. | 4.59% |
| 5 | LEGN | Legend Biotech Corporation | 4.41% |
| 6 | QGEN | Qiagen N.V. | 4.34% |
| 7 | RNA | Avidity Biosciences, Inc. | 4.15% |
| 8 | GH | Guardant Health, Inc. | 3.98% |
| 9 | TECH | Bio-Techne Corporation | 3.92% |
| 10 | NTRA | Natera, Inc. | 3.80% |
| 11 | BNTX | BioNTech SE | 3.72% |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | 3.62% |
| 13 | BMRN | BioMarin Pharmaceutical Inc. | 3.58% |
| 14 | RARE | Ultragenyx Pharmaceutical Inc. | 2.78% |
| 15 | HKG: 1548 | Genscript Biotech Corporation | 2.71% |
| 16 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.60% |
| 17 | TWST | Twist Bioscience Corporation | 2.58% |
| 18 | WGS | GeneDx Holdings Corp. | 2.49% |
| 19 | VCYT | Veracyte, Inc. | 2.41% |
| 20 | BEAM | Beam Therapeutics Inc. | 2.15% |
| 21 | A | Agilent Technologies, Inc. | 2.05% |
| 22 | GILD | Gilead Sciences, Inc. | 1.96% |
| 23 | LON: AZN | AstraZeneca PLC | 1.93% |
| 24 | BMY | Bristol-Myers Squibb Company | 1.85% |
| 25 | LLY | Eli Lilly and Company | 1.81% |
As of Jul 16, 2025